2,967
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Trajectories of psychological distress during recovery from polysubstance use disorder

ORCID Icon, , , , &
Pages 64-71 | Received 31 Oct 2019, Accepted 13 Feb 2020, Published online: 11 Mar 2020

References

  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Publishing.
  • Andersson HW, Steinsbekk A, Walderhaug E, Otterholt E, Nordfjaern T. 2018. Predictors of dropout from inpatient substance use treatment: a prospective cohort study. Subst Abuse. 12:1–10.
  • Andersson HW, Wenaas M, Nordfjaern T. 2019. Relapse after inpatient substance use treatment: a prospective cohort study among users of illicit substances. Addict Behav. 90:222–228.
  • Andreas JB, Lauritzen G, Nordfjaern T. 2015. Co-occurrence between mental distress and poly-drug use: a ten year prospective study of patients from substance abuse treatment. Addict Behav. 48:71–78.
  • Babor TF, de la Fuente JR, Saunders J, Grant M. 1989. AUDIT: the Alcohol Use Disorders Identification Test: guidelines for use in primary health care. Geneva: World Health Organization; p. 894.
  • Bakken K, Landheim AS, Vaglum P. 2007. Axis I and II disorders as long-term predictors of mental distress: a six-year prospective follow-up of substance-dependent patients. BMC Psychiatry. 7(1):29.
  • Bergly TH, Nordfjaern T, Hagen R. 2014. The dimensional structure of SCL-90-R in a sample of patients with substance use disorder. J Subst Use. 19(3):257–261.
  • Berman AH, Bergman H, Palmstierna T, Schlyter F. 2005. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 11(1):22–31.
  • Bhalla IP, Stefanovics EA, Rosenheck RA. 2017. Clinical epidemiology of single versus multiple substance use disorders: polysubstance use disorder. Med Care. 55:2:S24–S32.
  • Booth B, Curran G, Han X, Wright P, Frith S, Leukefeld C, Falck R, Carlson R. 2010. Longitudinal relationship between psychological distress and multiple substance use: results from a three-year multisite natural-history study of rural stimulant users. J Stud Alcohol Drugs. 71(2):258–267.
  • Brooner RK, King VL, Kidorf M, Schmidt CW, Jr., Bigelow GE. 1997. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 54(1):71–80.
  • Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. 1998. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 158(16):1789–1795.
  • Choi NG, DiNitto DM. 2019. Older marijuana users in substance abuse treatment: treatment settings for marijuana-only versus polysubstance use admissions. J Subst Abuse Treat. 105:28–36.
  • Connor JP, Gullo MJ, Chan G, Young RM, Hall WD, Feeney GF. 2013. Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and cannabis-related beliefs. Front Psychiatry. 4:79.
  • Connor JP, Gullo MJ, White A, Kelly AB. 2014. Polysubstance use: diagnostic challanges, patterns of use and health. Curr Opin Psychiatry. 27(4):269–275.
  • Daughters SB, Lejuez CW, Kahler CW, Strong DR, Brown RA. 2005. Psychological distress tolerance and duration of most recent abstinence attempt among residential treatment-seeking substance abusers. Psychol Addict Behav. 19(2):208–211.
  • De Soto CB, O’Donnell WE, Allred LJ, Lopes CE. 1985. Symptomatology in alcoholics at various stages of abstinence. Alcoholism Clin Exp Res. 9(6):505–512.
  • Delgadillo J, Bohnke JR, Hughes E, Gilbody S. 2016. Disentangling psychopathology, substance use and dependence: a factor analysis. BMC Psychiatry. 16:281.
  • Dennis M, Foss M, Scott C. 2007. An eight-year perspective on the relationship between the duration of abstinence and other aspects of recovery. Eval Rev. 31(6):585–612.
  • Dennis M, Scott CK. 2007. Managing addiction as a chronic condition. ASCP. 4(1):45–55.
  • Derogatis LR. 1994. Symptom checklist-90-R: administration, scoring & procedure manual for the revised version of the SCL-90. Minneapolis (MN): National Computer Systems.
  • Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. 2008. A meta-analytic review of psychosocial interventions for substance use disorders. AJP. 165(2):179–187.
  • Faul F, Erdfelder E, Lang AG, Buchner A. 2007. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 39(2):175–191.
  • Fleury M.-J, Djouini A, Huỳnh C, Tremblay J, Ferland F, Ménard J.-M, Belleville G. 2016. Remission from substance use disorders: a systematic review and meta-analysis. Drug Alcohol Depend. 168:293–306.
  • Flynn HA, Walton MA, Curran G, Blow FC, Knutzen S. 2004. Psychological distress and return to substance use two years following treatment. Subst Use Misuse. 39(6):885–910.
  • Gossop M, Marsden J, Stewart D. 2006. Remission of psychiatric symptoms among drug misusers after drug dependence treatment. J Nerv Ment Dis. 194(11):826–832.
  • Hagen E, Erga AH, Hagen KP, Nesvag SM, McKay JR, Lundervold AJ, Walderhaug E. 2016. Assessment of executive function in patients with substance use disorder: a comparison of inventory- and performance-based assessment. J Subst Abuse Treat. 66:1–8.
  • Hagen E, Erga AH, Hagen KP, Nesvag SM, McKay JR, Lundervold AJ, Walderhaug E. 2017. One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder. J Subst Abuse Treat. 76:81–87.
  • Hasin DS, O’Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, et al. 2013. DSM-5 criteria for substance use disorders: recommendations and rationale. AJP. 170(8):834–851.
  • Heradstveit O, Skogen JC, Hetland J, Hysing M. 2017. Alcohol and illicit drug use are important factors for school-related problems among adolescents. Front Psychol. 8:1023.
  • Hoxmark E, Benum V, Friborg O, Wynn R. 2010. Reduction in mental distress among substance users receiving inpatient treatment. Int J Ment Health Syst. 4(1):30.
  • Kelly A, Chan GC, Mason WA, Williams JW. 2015. The relationship between psychological distress and adolescent polydrug use. Psychol Addict Behav. 29(3):787–793.
  • Kelly A, Evans-Whipp T, Smith R, Chan G, Toumbourou J, Patton G, Hemphill S, Hall W, Catalano R. 2015. A longitudinal study of the association of adolescent polydrug use, alcohol use and high school non-completion. Addiction. 110(4):627–635.
  • Kleber H, Weiss R, George T, Kosten T, Rounsaville B, Ziedonis D, Disorders W. 2007. Treatment of patients with substance use disorders. 2nd ed. Am J Psychiatry. 164(4 Suppl):5–123.
  • Martin CS, Langenbucher JW, Chung T, Sher KJ. 2014. Truth or consequences in the diagnosis of substance use disorders. Addiction. 109(11):1773–1778.
  • McCabe SE, West BT, Jutkiewicz EM, Boyd CJ. 2017. Multiple DSM-5 substance use disorders: a national study of US adults. Hum Psychopharmacol. 32(5):e2625.
  • McPherson S, Barbosa-Leiker C, Burns GL, Howell D, Roll J. 2012. Missing data in substance abuse treatment research: current methods and modern approaches. Exp Clin Psychopharmacol. 20(3):243–250.
  • Palamar JJ, Le A, Mateu-Gelabert P. 2018. Not just heroin: extensive polysubstance use among US high school seniors who currently use heroin. Drug Alcohol Depend. 188:377–384.
  • Passos SR, Camacho LA. 2000. Factors associated with immediate dropout of outpatient treatment for drug abuse in Rio de Janeiro. Soc Psychiatry Psychiatr Epidemiol. 35(11):513–517.
  • Quek LH, Chan GC, White A, Connor JP, Baker PJ, Saunders JB, Kelly AB. 2013. Concurrent and simultaneous polydrug use: latent class analysis of an Australian nationally representative sample of young adults. Front Public Health. 1:61.
  • Riehman KS, Iguchi MY, Anglin MD. 2002. Depressive symptoms among amphetamine and cocaine users before and after substance abuse treatment. Psychol Addict Behav. 16(4):333–337.
  • Rubinsky AD, Dawson DA, Williams EC, Kivlahan DR, Bradley KA. 2013. AUDIT-C scores as a scaled marker of mean daily drinking, alcohol use disorder severity, and probability of alcohol dependence in a U.S. general population sample of drinkers. Alcohol Clin Exp Res. 37(8):1380–1390.
  • Salom CL, Betts KS, Williams GM, Najman JM, Alati R. 2016. Predictors of comorbid polysubstance use and mental health disorders in young adults-a latent class analysis. Addiction. 111(1):156–164.
  • Secades-Villa R, Fernández-Hermida JR. 2003. The validity of self-reports in a follow-up study with drug addicts. Addict Behav. 28(6):1175–1182.
  • Staines GL, Magura S, Foote J, Deluca A, Kosanke N. 2001. Polysubstance use among alcoholics. J Addict Dis. 20(4):57–73.
  • Stark M. 1992. Dropping out of substance abuse treatment: a clinically oriented review. Clin Psychol Rev. 12(1):93–116.
  • Subbaraman MS, Witbrodt J. 2014. Differences between abstinent and non-abstinent individuals in recovery from alcohol use disorders. Addict Behav. 39(12):1730–1735.
  • Svendsen TS, Erga AH, Hagen E, McKay JR, Njå ALM, Årstad J, Nesvåg S. 2017. How to maintain high retention rates in long-term research on addiction: a case report. J Soc Work Pract Addict. 17(4):374–387.
  • Thylstrup B, Bloomfield K, Hesse M. 2018. Incremental predictive validity of the Addiction Severity Index psychiatric composite score in a consecutive cohort of patients in residential treatment for drug use disorders. Addict Behav. 76:201–207.
  • Timko C, Han X, Woodhead E, Shelley A, Cucciare MA. 2018. Polysubstance use by stimulant users: health outcomes over three years. J Stud Alcohol Drugs. 79(5):799–807.
  • Tomasson K, Vaglum P. 1997. The 2-year course following detoxification treatment of substance abuse: the possible influence of psychiatric comorbidity. Eur Arch Psychiatry Clin Neurosci. 247(6):320–327.
  • Vaillant GE. 1988. What can long-term follow-up teach us about relapse and prevention of relapse in addiction? Addiction. 83(10):1147–1157.
  • Williams EC, Rubinsky AD, Chavez LJ, Lapham GT, Rittmueller SE, Achtmeyer CE, Bradley KA. 2014. An early evaluation of implementation of brief intervention for unhealthy alcohol use in the US Veterans Health Administration. Addiction. 109(9):1472–1481.
  • World Health Organization. 1992. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.